15% OFF $150+· CodeFALL15
Ends October 15Shop now
Lot certificates published
Discreet shipping

Compound monograph

SHLP3

SHLP3 is a 38-residue peptide from the same mitochondrial region as humanin, characterised principally through the study that named the series.

Published: 2026-09-16Literature/identifier verification: 2026-09-15

01

Identity & nomenclature

SHLP3 is a 38-residue peptide from the same mitochondrial region as humanin, characterised principally through the study that named the series.

The number denotes a distinct peptide, not an activity rank and not a shortened humanin. Mature endogenous termini and intact endogenous sequence confirmation are UNKNOWN; a synthetic peptide showing activity does not demonstrate that the same mature molecule is produced physiologically.

Canonical name: Small humanin-like peptide 3.

Declared aliases and development codes: SHLP-3.

02

Molecular properties

Molecular formulaC214H301N47O49S2
Molecular mass4380.2 Da
One-letter sequenceMLGYNFSSFPCGTISIAPGFNFYRLYFIWVNGLAKVVW

Thirty-eight residues with free termini and a cysteine at position 11. The recorded sequence has valine at position 29; substitution with tryptophan would change both formula and mass.

03

Structural characteristics

The discovery study identified small open reading frames in the mitochondrial 16S rRNA region and found different cellular responses among the SHLP peptides. SHLP3 induced ERK phosphorylation without detectable STAT3 phosphorylation in the reported comparison. No direct receptor assignment is established here. The conservation analysis found no significant synonymous codon bias and poor conservation for SHLP3, arguing against amino-acid sequence constraint despite the reported cellular observations.

Terminal features: Free N-terminus, Free C-terminal carboxyl.

04

Molecular targets & mechanisms

05

Analytical considerations

Sequence confirmation should distinguish valine from tryptophan at position 29 and establish both termini. One cysteine permits intermolecular disulfide formation, and methionine oxidation changes mass. A matching retention time or nominal mass does not establish residue order or leucine/isoleucine assignments.

06

Verified bibliography

  1. Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers.

    Cobb LJ, Lee C, Xiao J, Yen K, Wong RG, Nakamura HK, Mehta HH, Gao Q, Ashur C, Huffman DM, Wan J, Muzumdar R, Barzilai N, Cohen P

    Aging · 2016-04 · Journal Article

    current
  2. Evidence of natural selection in the mitochondrial-derived peptides humanin and SHLP6.

    Gruschus JM, Morris DL, Tjandra N

    Scientific reports · 2023-08-29 · Journal Article

    current
  3. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.

    Lee C, Zeng J, Drew BG, Sallam T, Martin-Montalvo A, Wan J, Kim SJ, Mehta H, Hevener AL, de Cabo R, Cohen P

    Cell metabolism · 2015-03-03 · Journal Article

    current

10

Methodology & citation verification

Reference identity is checked against official PubMed metadata. Local deterministic receipts bind each normalized title and canonical metadata record to its verification date. Scientific values remain absent when an authoritative source has not been verified.

Read the full methodology →